BioLargo, Inc. BLGO
$0.09
$0.00-1.97%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.04% | 22.59% | 54.43% | -443.62% | -3.20% |
| Total Depreciation and Amortization | 1.80% | -18.98% | 33.01% | 27.16% | -4.71% |
| Total Amortization of Deferred Charges | 12.90% | -31.11% | 130.77% | 0.00% | 39.29% |
| Total Other Non-Cash Items | 33.26% | -1,027.08% | -98.77% | 24,550.00% | 75.38% |
| Change in Net Operating Assets | 51.25% | -133.00% | 426.73% | 67.67% | -42.46% |
| Cash from Operations | -4.77% | -83.46% | 42.37% | -30.26% | -15.74% |
| Capital Expenditure | -400.00% | -146.15% | 60.61% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 50.52% | -- |
| Cash from Investing | -400.00% | -146.15% | -105.08% | 33.33% | -- |
| Total Debt Issued | -58.25% | 9,311.54% | -- | -100.00% | 22.20% |
| Total Debt Repaid | -1,675.00% | -144.44% | 300.00% | -80.00% | -25.00% |
| Issuance of Common Stock | 14.66% | -64.48% | -68.40% | 283.10% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -93.51% | -- | -- | -221.15% | 372.86% |
| Cash from Financing | -59.91% | 235.08% | -73.33% | 26.01% | 227.14% |
| Foreign Exchange rate Adjustments | 250.00% | 83.33% | -250.00% | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -909.21% | 136.05% | -161.67% | 18.52% | 192.17% |